RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AbL Diagnostics Stock

AbL Diagnostics P/S 2024

AbL Diagnostics P/S

13.78

Ticker

ABLD.PA

ISIN

FR001400AHX6

WKN

A3DL82

As of Sep 22, 2024, AbL Diagnostics's P/S ratio stood at 13.78, a 155.19% change from the 5.4 P/S ratio recorded in the previous year.

The AbL Diagnostics P/S history

AbL Diagnostics Aktienanalyse

What does AbL Diagnostics do?

AbL Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding AbL Diagnostics's P/S Ratio

AbL Diagnostics's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing AbL Diagnostics's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating AbL Diagnostics's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in AbL Diagnostics’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about AbL Diagnostics stock

What is the price-to-earnings ratio of AbL Diagnostics?

The price-earnings ratio of AbL Diagnostics is currently 13.78.

How has the price-earnings ratio of AbL Diagnostics changed compared to last year?

The price-to-earnings ratio of AbL Diagnostics has increased by 155.19% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of AbL Diagnostics high compared to other companies?

Yes, the price-to-earnings ratio of AbL Diagnostics is high compared to other companies.

How does an increase in the price-earnings ratio of AbL Diagnostics affect the company?

An increase in the price-earnings ratio of AbL Diagnostics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of AbL Diagnostics affect the company?

A decrease in the price-earnings ratio of AbL Diagnostics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of AbL Diagnostics?

Some factors that influence the price-earnings ratio of AbL Diagnostics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does AbL Diagnostics pay?

Over the past 12 months, AbL Diagnostics paid a dividend of 2.31 EUR . This corresponds to a dividend yield of about 82.59 %. For the coming 12 months, AbL Diagnostics is expected to pay a dividend of 0 EUR.

What is the dividend yield of AbL Diagnostics?

The current dividend yield of AbL Diagnostics is 82.59 %.

When does AbL Diagnostics pay dividends?

AbL Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AbL Diagnostics?

AbL Diagnostics paid dividends every year for the past 0 years.

What is the dividend of AbL Diagnostics?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is AbL Diagnostics located?

AbL Diagnostics is assigned to the 'Industry' sector.

Wann musste ich die Aktien von AbL Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AbL Diagnostics from 10/5/2020 amounting to 18.5 EUR, you needed to have the stock in your portfolio before the ex-date on 10/1/2020.

When did AbL Diagnostics pay the last dividend?

The last dividend was paid out on 10/5/2020.

What was the dividend of AbL Diagnostics in the year 2023?

In the year 2023, AbL Diagnostics distributed 0 EUR as dividends.

In which currency does AbL Diagnostics pay out the dividend?

The dividends of AbL Diagnostics are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AbL Diagnostics

Our stock analysis for AbL Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AbL Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.